Bispecific CD20-directed CD3 T Cell Engager [EPC]

Bispecific CD20-directed CD3 T Cell Engager [EPC] was reported 4045 times

Drugs of the Bispecific CD20-directed CD3 T Cell Engager [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HIGH GRADE B-CELL LYMPHOMA REFRACTORY 4 1.0000
1 HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA REFRACTORY 4 0.8000
2 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 252 0.2661
3 HAEMORRHAGIC GASTROENTERITIS 1 0.2000
4 B-CELL LYMPHOMA REFRACTORY 12 0.1348
5 HERPETIC RADICULOPATHY 1 0.1250
6 EUSTACHIAN TUBE STENOSIS 1 0.1250
7 PRIMARY CARDIAC LYMPHOMA 2 0.1250
8 BLOOD TYPE INCOMPATIBILITY 1 0.1250
9 FOLLICULAR LYMPHOMA REFRACTORY 7 0.1077
10 HEPATOBILIARY NEOPLASM 1 0.1000
11 ACUTE NECROTISING MYELITIS 1 0.1000
12 TUMOUR FLARE 66 0.0966
13 HIGH GRADE B-CELL LYMPHOMA RECURRENT 1 0.0909
14 ATYPICAL LYMPHOCYTES INCREASED 2 0.0909
15 KNUCKLE PADS 2 0.0870
16 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV 1 0.0833
17 LEUKAEMIC LYMPHOMA 3 0.0789
18 CYTOKINE RELEASE SYNDROME 1317 0.0656
19 CD19 ANTIGEN LOSS 1 0.0625
20 FACTOR XI DEFICIENCY 1 0.0500
21 CD19 LYMPHOCYTE COUNT ABNORMAL 1 0.0476
22 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 264 0.0445
23 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 97 0.0440
24 DIAPHRAGM NEOPLASM 1 0.0435
25 DIFFUSE LARGE B-CELL LYMPHOMA 299 0.0388
26 COR PULMONALE CHRONIC 7 0.0372
27 ASCENDING FLACCID PARALYSIS 1 0.0370
28 GASTROINTESTINAL EXAMINATION ABNORMAL 1 0.0357
29 INTERLEUKIN-2 RECEPTOR INCREASED 6 0.0351
30 TUMOUR ASSOCIATED FEVER 14 0.0342
31 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 4 0.0342
32 AORTIC PSEUDOANEURYSM 2 0.0339
33 CAMPYLOBACTER BACTERAEMIA 1 0.0333
34 FOLLICULAR LYMPHOMA 26 0.0295
35 CONGENITAL APLASIA 9 0.0289
36 FUNGAL MYOSITIS 1 0.0286
37 HIGH-GRADE B-CELL LYMPHOMA 5 0.0267
38 FOLLICULAR LYMPHOMA STAGE III 1 0.0250
39 CITROBACTER SEPSIS 1 0.0250
40 HAIRY CELL LEUKAEMIA RECURRENT 1 0.0244
41 BLOOD LACTATE DEHYDROGENASE DECREASED 8 0.0240
42 TUMOUR PSEUDOPROGRESSION 25 0.0228
43 MANTLE CELL LYMPHOMA 33 0.0217
44 ENCEPHALITIS CYTOMEGALOVIRUS 9 0.0205
45 CYTOMEGALOVIRUS INFECTION REACTIVATION 89 0.0201
46 DOUBLE HIT LYMPHOMA 1 0.0200
47 CYTOMEGALOVIRUS GASTRITIS 5 0.0198
48 BLOOD CATECHOLAMINES DECREASED 1 0.0196
49 FUNGATING WOUND 1 0.0192
50 CATHETER SITE PHLEBITIS 1 0.0192
51 COAGULATION FACTOR XIII LEVEL DECREASED 1 0.0192
52 TUMOUR INFLAMMATION 2 0.0179
53 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 3 0.0173
54 CAROTID SINUS SYNDROME 1 0.0167
55 NECROTIC LYMPHADENOPATHY 2 0.0167
56 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0158
57 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 5 0.0152
58 CYTOMEGALOVIRUS TEST POSITIVE 26 0.0146
59 ADENOVIRAL HAEMORRHAGIC CYSTITIS 3 0.0144
60 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
61 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 2 0.0132
62 B-CELL LYMPHOMA RECURRENT 7 0.0129
63 HYPERAMYLASAEMIA 7 0.0128
64 HISTIOCYTIC SARCOMA 1 0.0128
65 FOLLICULAR LYMPHOMA RECURRENT 1 0.0125
66 GENITOURINARY TRACT NEOPLASM 1 0.0120
67 CYTOMEGALOVIRUS ENTEROCOLITIS 9 0.0117
68 ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED 1 0.0116
69 SOCIOECONOMIC PRECARITY 2 0.0116
70 ACCESSORY SPLEEN 1 0.0111
71 INTERLEUKIN LEVEL INCREASED 6 0.0109
72 HYPOGAMMAGLOBULINAEMIA 71 0.0108
73 PORIOMANIA 2 0.0105
74 TUMOUR INVASION 5 0.0103
75 BACILLUS TEST POSITIVE 1 0.0101
76 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
77 DUODENAL OBSTRUCTION 3 0.0100
78 PARVOVIRUS INFECTION 4 0.0099
79 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
80 URETERAL DISORDER 4 0.0097
81 CYTOMEGALOVIRUS GASTROENTERITIS 2 0.0093
82 HYPERPYREXIA 39 0.0092
83 BACILLUS BACTERAEMIA 1 0.0092
84 ACUTE HEPATITIS B 3 0.0090
85 BLOOD ELECTROLYTES INCREASED 1 0.0085
86 PLEURAL DISORDER 5 0.0080
87 CD19 LYMPHOCYTES DECREASED 1 0.0077
88 HERPES ZOSTER REACTIVATION 2 0.0076
89 CYTOKINE INCREASED 1 0.0074
90 BRONCHIAL NEOPLASM 1 0.0074
91 ENTEROCOLITIS BACTERIAL 2 0.0072
92 DISSEMINATED NOCARDIOSIS 1 0.0072
93 SYSTEMIC CANDIDA 18 0.0072
94 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 1 0.0070
95 SECONDARY IMMUNODEFICIENCY 8 0.0066
96 MYOCARDIAL INJURY 7 0.0062
97 GIARDIASIS 2 0.0059
98 PSEUDOMONAL BACTERAEMIA 5 0.0059
99 CYTOMEGALOVIRUS VIRAEMIA 26 0.0058
100 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1 0.0057
101 JC VIRUS INFECTION 9 0.0056
102 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 2 0.0055
103 HERPES ZOSTER MENINGITIS 1 0.0055
104 ENTEROBACTER SEPSIS 2 0.0054
105 B-LYMPHOCYTE COUNT INCREASED 1 0.0054
106 CEREBELLAR ISCHAEMIA 1 0.0054
107 ACINETOBACTER BACTERAEMIA 1 0.0053
108 HAEMATOPOIETIC NEOPLASM 1 0.0053
109 TUMOUR PAIN 7 0.0053
110 THROMBOTIC CEREBRAL INFARCTION 2 0.0053
111 ANISOCORIA 2 0.0053
112 NEUTROPENIC INFECTION 5 0.0052
113 HYPOFIBRINOGENAEMIA 5 0.0050
114 CUTANEOUS LYMPHOMA 1 0.0049
115 UREAPLASMA INFECTION 2 0.0049
116 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
117 CD4 LYMPHOCYTES ABNORMAL 1 0.0048
118 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 10 0.0047
119 EMPHYSEMATOUS CYSTITIS 1 0.0047
120 IMMOBILISATION SYNDROME 1 0.0047
121 CLOSTRIDIUM BACTERAEMIA 1 0.0047
122 TUMOUR LYSIS SYNDROME 41 0.0047
123 HYPERFERRITINAEMIA 2 0.0046
124 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
125 MANTLE CELL LYMPHOMA RECURRENT 2 0.0046
126 C-REACTIVE PROTEIN DECREASED 3 0.0046
127 GLOSSOPTOSIS 1 0.0046
128 CHRONIC GRAFT VERSUS HOST DISEASE 16 0.0044
129 AORTITIS 3 0.0044
130 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
131 BONE MARROW NECROSIS 1 0.0043
132 CREST SYNDROME 1 0.0042
133 AGNOSIA 1 0.0042
134 DISEASE PROGRESSION 494 0.0042
135 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
136 PNEUMONIA HAEMOPHILUS 2 0.0041
137 DEVICE RELATED THROMBOSIS 4 0.0041
138 INFECTIVE ANEURYSM 2 0.0040
139 BLOOD IMMUNOGLOBULIN G DECREASED 10 0.0040
140 METASTASES TO BONE MARROW 2 0.0040
141 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 30 0.0040
142 GASTROINTESTINAL LYMPHOMA 1 0.0038
143 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
144 CYTOTOXIC OEDEMA 1 0.0038
145 HERPES ZOSTER DISSEMINATED 3 0.0037
146 HYPOALBUMINAEMIA 29 0.0037
147 INTERVERTEBRAL DISCITIS 7 0.0037
148 BLOOD LACTATE DEHYDROGENASE INCREASED 58 0.0037
149 CATHETER SITE THROMBOSIS 1 0.0036
150 COVID-19 PNEUMONIA 43 0.0036
151 INJECTION RELATED REACTION 6 0.0036
152 DUCTAL ADENOCARCINOMA OF PANCREAS 1 0.0036
153 BULBAR PALSY 1 0.0036
154 KLEBSIELLA SEPSIS 4 0.0035
155 GENITOURINARY TRACT INFECTION 1 0.0035
156 B-CELL LYMPHOMA 12 0.0035
157 BLOOD FIBRINOGEN DECREASED 4 0.0035
158 CHOROIDAL NEOVASCULARISATION 3 0.0035
159 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
160 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
161 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 2 0.0034
162 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 1 0.0034
163 SUSPECTED OFF LABEL USE 15 0.0033
164 GASTRIC PERFORATION 9 0.0033
165 ENTEROCOLITIS VIRAL 1 0.0033
166 MARASMUS 5 0.0033
167 ENCEPHALITIS VIRAL 4 0.0033
168 ASPERGILLUS TEST POSITIVE 1 0.0032
169 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
170 GRANULOCYTE COUNT DECREASED 6 0.0032
171 BILIARY TRACT INFECTION 2 0.0032
172 CHRONIC HEPATITIS B 1 0.0032
173 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
174 COLORECTAL ADENOMA 1 0.0031
175 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
176 KLEBSIELLA TEST POSITIVE 2 0.0031
177 DIABETIC HYPERGLYCAEMIC COMA 1 0.0031
178 BLOOD IMMUNOGLOBULIN M DECREASED 3 0.0030
179 CYTOKINE STORM 2 0.0029
180 CENTRAL NERVOUS SYSTEM LYMPHOMA 4 0.0029
181 FUNGAL TEST POSITIVE 1 0.0028
182 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 4 0.0028
183 CYTOMEGALOVIRUS ENTERITIS 1 0.0028
184 EYE SYMPTOM 1 0.0028
185 CYTOMEGALOVIRUS INFECTION 46 0.0028
186 DYSLALIA 2 0.0028
187 APALLIC SYNDROME 2 0.0028
188 GLOBULINS INCREASED 1 0.0027
189 EAR OPERATION 1 0.0027
190 OTITIS MEDIA ACUTE 2 0.0027
191 BRONCHOPNEUMOPATHY 1 0.0027
192 CYTOMEGALOVIRUS OESOPHAGITIS 1 0.0027
193 HUMORAL IMMUNE DEFECT 1 0.0027
194 ACETABULUM FRACTURE 1 0.0027
195 HEPATITIS B CORE ANTIBODY POSITIVE 1 0.0027
196 METASTASES TO MENINGES 6 0.0026
197 HYPOPROTEINAEMIA 5 0.0026
198 HERPES SIMPLEX REACTIVATION 1 0.0026
199 CONJUNCTIVAL DISORDER 1 0.0026
200 T-CELL LYMPHOMA 3 0.0026
201 BONE MARROW INFILTRATION 1 0.0026
202 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
203 PROCALCITONIN INCREASED 3 0.0026
204 BLOOD FIBRINOGEN INCREASED 2 0.0025
205 PNEUMONIA FUNGAL 10 0.0025
206 PNEUMONIA MYCOPLASMAL 2 0.0025
207 BONE DENSITY INCREASED 1 0.0025
208 PNEUMONIA BACTERIAL 23 0.0025
209 VASCULAR ACCESS COMPLICATION 2 0.0025
210 HAEMATOLOGICAL INFECTION 6 0.0025
211 PSEUDOMONAS TEST POSITIVE 2 0.0024
212 POST-ACUTE COVID-19 SYNDROME 3 0.0024
213 VARICELLA ZOSTER VIRUS INFECTION 5 0.0024
214 GASTROINTESTINAL CANDIDIASIS 1 0.0024
215 ENTEROVIRUS INFECTION 2 0.0023
216 HERPES OPHTHALMIC 3 0.0023
217 FACIAL NERVE DISORDER 1 0.0023
218 ABDOMINAL NEOPLASM 2 0.0022
219 ORGANISING PNEUMONIA 11 0.0022
220 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
221 BACTERIAL INFECTION 40 0.0021
222 SMALL INTESTINAL PERFORATION 4 0.0021
223 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
224 INTRACRANIAL MASS 2 0.0021
225 KLEBSIELLA BACTERAEMIA 2 0.0021
226 NEUTROPHIL COUNT DECREASED 84 0.0021
227 CARDIAC VALVE VEGETATION 1 0.0021
228 ENCEPHALITIS HERPES 1 0.0020
229 STEROID DIABETES 3 0.0020
230 CSF TEST ABNORMAL 1 0.0020
231 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 2 0.0020
232 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
233 PNEUMONIA PSEUDOMONAL 3 0.0020
234 CEREBRAL ARTERY THROMBOSIS 1 0.0019
235 GRAFT VERSUS HOST DISEASE 14 0.0019
236 URETEROLITHIASIS 2 0.0019
237 HEPATITIS E 3 0.0019
238 TUMOUR NECROSIS 2 0.0019
239 ENTEROCOCCAL BACTERAEMIA 2 0.0019
240 CORYNEBACTERIUM INFECTION 1 0.0019
241 FEBRILE NEUTROPENIA 124 0.0019
242 HYPERTRANSAMINASAEMIA 13 0.0019
243 BLOOD GASES ABNORMAL 1 0.0019
244 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
245 BRONCHOSTENOSIS 1 0.0018
246 ADRENAL HAEMORRHAGE 1 0.0018
247 INTESTINAL PERFORATION 20 0.0018
248 HEPATORENAL SYNDROME 3 0.0018
249 SARCOMA 2 0.0018
250 VITH NERVE PARALYSIS 2 0.0018
251 SERUM FERRITIN INCREASED 9 0.0017
252 FEBRILE INFECTION 2 0.0017
253 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
254 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
255 DIAPHRAGMATIC PARALYSIS 1 0.0017
256 NEUTROPENIA 227 0.0017
257 BONE MARROW DISORDER 5 0.0017
258 SOFT TISSUE INFECTION 3 0.0016
259 CYTOPENIA 20 0.0016
260 CANCER PAIN 4 0.0016
261 AUTOIMMUNE COLITIS 1 0.0016
262 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0015
263 VASCULAR DEVICE INFECTION 7 0.0015
264 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
265 ILEAL PERFORATION 1 0.0015
266 ORGAN FAILURE 6 0.0015
267 HYDRONEPHROSIS 11 0.0015
268 IMMUNOGLOBULINS DECREASED 2 0.0015
269 CAPILLARY LEAK SYNDROME 3 0.0014
270 BACTERAEMIA 17 0.0014
271 CRANIAL NERVE DISORDER 1 0.0014
272 FUSARIUM INFECTION 1 0.0014
273 LYMPHOMA 22 0.0014
274 MALIGNANT NEOPLASM PROGRESSION 143 0.0014
275 INVESTIGATION ABNORMAL 2 0.0014
276 POST HERPETIC NEURALGIA 2 0.0014
277 MYELOSUPPRESSION 50 0.0014
278 GASTROINTESTINAL SCARRING 1 0.0014
279 PANCREATIC ENZYMES INCREASED 2 0.0014
280 COMA HEPATIC 1 0.0013
281 ACUTE MYELOID LEUKAEMIA 21 0.0013
282 LARGE INTESTINAL OBSTRUCTION 3 0.0013
283 ARTERIAL INJURY 1 0.0013
284 ADENOCARCINOMA 3 0.0013
285 HEART SOUNDS ABNORMAL 1 0.0013
286 CHOLANGITIS ACUTE 1 0.0013
287 ENTEROVESICAL FISTULA 1 0.0013
288 PALLIATIVE CARE 2 0.0013
289 CYTOMEGALOVIRUS COLITIS 3 0.0013
290 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
291 ALANINE AMINOTRANSFERASE INCREASED 79 0.0013
292 PERFORMANCE STATUS DECREASED 6 0.0013
293 RHINOVIRUS INFECTION 5 0.0013
294 ESCHERICHIA BACTERAEMIA 3 0.0013
295 INTESTINAL ISCHAEMIA 7 0.0013
296 FUNGAEMIA 2 0.0013
297 HEPATITIS B REACTIVATION 4 0.0013
298 HEPATIC CYTOLYSIS 16 0.0013
299 SEPTIC SHOCK 54 0.0012
300 ENTEROCOCCAL SEPSIS 1 0.0012
301 BACTERIAL SEPSIS 4 0.0012
302 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
303 SEBORRHOEIC DERMATITIS 2 0.0012
304 CSF PROTEIN INCREASED 1 0.0012
305 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
306 CAMPYLOBACTER INFECTION 1 0.0012
307 SECOND PRIMARY MALIGNANCY 10 0.0012
308 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
309 ENTERITIS INFECTIOUS 2 0.0012
310 DISSEMINATED TUBERCULOSIS 3 0.0012
311 POLYNEUROPATHY 14 0.0012
312 HEPATIC LESION 5 0.0012
313 GASTROINTESTINAL NEOPLASM 1 0.0012
314 LARGE INTESTINE PERFORATION 8 0.0012
315 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
316 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
317 ENTEROCUTANEOUS FISTULA 1 0.0011
318 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
319 NEUTROPENIC SEPSIS 8 0.0011
320 CANDIDA SEPSIS 1 0.0011
321 BLOOD MAGNESIUM INCREASED 1 0.0011
322 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 9 0.0011
323 ENTEROCOLITIS INFECTIOUS 1 0.0011
324 PUPILLARY REFLEX IMPAIRED 2 0.0011
325 C-REACTIVE PROTEIN 1 0.0011
326 LEUKOENCEPHALOPATHY 4 0.0011
327 ASPERGILLUS INFECTION 7 0.0011
328 PYREXIA 369 0.0011
329 THROMBOCYTOPENIA 119 0.0011
330 PROTEIN TOTAL DECREASED 4 0.0011
331 LYMPHOPENIA 15 0.0011
332 BRAIN STEM HAEMORRHAGE 1 0.0011
333 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
334 HAEMATOTOXICITY 10 0.0011
335 TUMOUR HAEMORRHAGE 3 0.0011
336 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
337 FOREIGN BODY IN EYE 1 0.0010
338 HYPOCOAGULABLE STATE 1 0.0010
339 COVID-19 180 0.0010
340 HAEMOPHILUS INFECTION 1 0.0010
341 CELL DEATH 2 0.0010
342 BLADDER CANCER RECURRENT 1 0.0010
343 DEVICE RELATED SEPSIS 2 0.0010
344 C-REACTIVE PROTEIN INCREASED 36 0.0010
345 SUDDEN HEARING LOSS 2 0.0010
346 NEOPLASM PROGRESSION 34 0.0010
347 HYPERCALCAEMIA 12 0.0010
348 NEUROTOXICITY 17 0.0010
349 BREAST NEOPLASM 1 0.0010
350 NEUTROPENIC COLITIS 2 0.0010
351 LYMPHOCYTE COUNT DECREASED 17 0.0010
352 INTENTIONAL UNDERDOSE 7 0.0010
353 INFECTION 138 0.0010
354 HYPOPHOSPHATAEMIA 7 0.0009
355 PNEUMONIA VIRAL 3 0.0009
356 HYPERPHOSPHATAEMIA 2 0.0009
357 BLOOD BILIRUBIN INCREASED 25 0.0009
358 ACARODERMATITIS 1 0.0009
359 ACINETOBACTER INFECTION 1 0.0009
360 PLATELET COUNT DECREASED 96 0.0009
361 INTERCEPTED PRODUCT PREPARATION ERROR 11 0.0009
362 CYTOGENETIC ABNORMALITY 1 0.0009
363 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
364 TEMPERATURE INTOLERANCE 9 0.0009
365 NEOPLASM 10 0.0009
366 ENTEROCOLITIS 5 0.0009
367 NEUROLOGICAL DECOMPENSATION 2 0.0009
368 HYPOXIA 30 0.0009
369 SINUS TACHYCARDIA 12 0.0008
370 URINARY TRACT OBSTRUCTION 2 0.0008
371 HAEMATOMA MUSCLE 1 0.0008
372 BONE LESION 3 0.0008
373 MYELODYSPLASTIC SYNDROME 12 0.0008
374 CHRONIC RESPIRATORY FAILURE 1 0.0008
375 BLEEDING TIME PROLONGED 1 0.0008
376 CLOSTRIDIUM COLITIS 1 0.0008
377 BRONCHITIS CHRONIC 2 0.0008
378 CARDIAC DYSFUNCTION 3 0.0008
379 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
380 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
381 METASTASES TO PERITONEUM 2 0.0008
382 HEPATOSPLENOMEGALY 2 0.0008
383 PHYSICAL DECONDITIONING 2 0.0008
384 BLOOD CHLORIDE DECREASED 2 0.0008
385 MUCORMYCOSIS 2 0.0008
386 LYMPHADENOPATHY 27 0.0008
387 ENCEPHALITIS AUTOIMMUNE 1 0.0008
388 DYSGRAPHIA 5 0.0008
389 LUNG OPACITY 2 0.0008
390 IMMUNE SYSTEM DISORDER 10 0.0008
391 CORONAVIRUS INFECTION 5 0.0008
392 CARDIAC FAILURE ACUTE 5 0.0007
393 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
394 DELIRIUM 26 0.0007
395 ABDOMINAL MASS 2 0.0007
396 ANAEMIA 141 0.0007
397 SPINAL STENOSIS 3 0.0007
398 GASTROINTESTINAL PERFORATION 3 0.0007
399 SEPSIS 79 0.0007
400 NECK MASS 2 0.0007
401 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
402 LUNG NEOPLASM 3 0.0007
403 PNEUMATOSIS INTESTINALIS 2 0.0007
404 PNEUMONITIS 19 0.0007
405 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
406 SHOCK 16 0.0007
407 BLOOD URIC ACID INCREASED 4 0.0007
408 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
409 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
410 HYPERBILIRUBINAEMIA 7 0.0007
411 APRAXIA 1 0.0007
412 CHOLANGIOCARCINOMA 1 0.0007
413 LUNG ADENOCARCINOMA 2 0.0007
414 HEPATITIS B 4 0.0007
415 PANCYTOPENIA 37 0.0007
416 LUMBAR VERTEBRAL FRACTURE 3 0.0007
417 GENITAL HERPES 1 0.0007
418 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
419 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
420 NON-CARDIAC CHEST PAIN 2 0.0006
421 METASTASES TO LIVER 11 0.0006
422 CYSTITIS INTERSTITIAL 1 0.0006
423 ENTEROCOCCAL INFECTION 3 0.0006
424 SHOCK HAEMORRHAGIC 5 0.0006
425 HYPOVENTILATION 2 0.0006
426 STAPHYLOCOCCAL SEPSIS 3 0.0006
427 SARS-COV-2 TEST POSITIVE 8 0.0006
428 INFLAMMATORY MARKER INCREASED 3 0.0006
429 MENINGITIS 4 0.0006
430 FULL BLOOD COUNT DECREASED 12 0.0006
431 PLEURAL EFFUSION 36 0.0006
432 TACHYPNOEA 8 0.0006
433 GAZE PALSY 1 0.0006
434 FEMORAL NECK FRACTURE 3 0.0006
435 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
436 PSEUDOMONAS INFECTION 5 0.0006
437 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
438 BLOOD CHLORIDE INCREASED 1 0.0006
439 MYOPATHY 5 0.0006
440 PYELONEPHRITIS 5 0.0006
441 EXTREMITY NECROSIS 1 0.0006
442 FUNGAL INFECTION 19 0.0006
443 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
444 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
445 ERYTHEMA OF EYELID 3 0.0006
446 DISORGANISED SPEECH 1 0.0005
447 AMYLASE INCREASED 2 0.0005
448 IMMUNODEFICIENCY 8 0.0005
449 MALNUTRITION 6 0.0005
450 AURA 1 0.0005
451 HEPATIC FUNCTION ABNORMAL 20 0.0005
452 RESPIRATORY FAILURE 39 0.0005
453 GRANULOCYTOPENIA 3 0.0005
454 NEUROLOGICAL SYMPTOM 3 0.0005
455 HEPATIC MASS 1 0.0005
456 THERAPY PARTIAL RESPONDER 8 0.0005
457 ABDOMINAL WALL HAEMATOMA 1 0.0005
458 SPLENOMEGALY 6 0.0005
459 ORAL INFECTION 2 0.0005
460 VIRAL INFECTION 17 0.0005
461 ASCITES 15 0.0005
462 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
463 ANORECTAL DISORDER 1 0.0005
464 LEUKOPENIA 25 0.0005
465 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
466 IMMUNE-MEDIATED HEPATITIS 1 0.0005
467 METASTASES TO BONE 8 0.0005
468 HYPERURICAEMIA 2 0.0005
469 AGRANULOCYTOSIS 9 0.0005
470 OLIGURIA 3 0.0005
471 LIVER DISORDER 21 0.0005
472 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
473 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
474 ENTERITIS 3 0.0005
475 PULMONARY TUBERCULOSIS 2 0.0005
476 THERAPY NON-RESPONDER 21 0.0005
477 CD4 LYMPHOCYTES DECREASED 1 0.0005
478 METASTATIC NEOPLASM 2 0.0005
479 HERPES SIMPLEX 3 0.0005
480 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
481 IMMOBILE 2 0.0005
482 DEVICE RELATED INFECTION 7 0.0005
483 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
484 DISTRIBUTIVE SHOCK 1 0.0004
485 PNEUMONIA 141 0.0004
486 PERITONITIS 9 0.0004
487 LOCALISED OEDEMA 2 0.0004
488 ATRIAL FIBRILLATION 42 0.0004
489 BILIRUBIN CONJUGATED INCREASED 1 0.0004
490 MUCOSAL INFLAMMATION 11 0.0004
491 CHOLECYSTITIS 5 0.0004
492 URINARY RETENTION 14 0.0004
493 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
494 DIABETES INSIPIDUS 1 0.0004
495 CANDIDA INFECTION 7 0.0004
496 GUILLAIN-BARRE SYNDROME 2 0.0004
497 OXYGEN SATURATION DECREASED 23 0.0004
498 GLOMERULONEPHRITIS 1 0.0004
499 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
500 OFF LABEL USE 356 0.0004
501 BLOOD PRESSURE DECREASED 27 0.0004
502 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
503 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
504 HYPERVOLAEMIA 2 0.0004
505 NO ADVERSE EVENT 73 0.0004
506 KETOACIDOSIS 3 0.0004
507 HYPERAMMONAEMIA 2 0.0004
508 DEATH 342 0.0004
509 DYSPHORIA 2 0.0004
510 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
511 PATHOLOGICAL FRACTURE 2 0.0004
512 HYPERTHERMIA 3 0.0004
513 INTERSTITIAL LUNG DISEASE 19 0.0004
514 ABDOMINAL INFECTION 1 0.0004
515 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
516 ACTINIC KERATOSIS 1 0.0004
517 NERVOUS SYSTEM DISORDER 12 0.0004
518 RESPIRATORY TRACT INFECTION 10 0.0004
519 BLOOD CREATININE INCREASED 25 0.0004
520 BLOOD LACTIC ACID INCREASED 2 0.0004
521 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
522 ATRIAL FLUTTER 3 0.0004
523 BLOOD POTASSIUM ABNORMAL 1 0.0004
524 BLOOD DISORDER 3 0.0004
525 HYPERLACTACIDAEMIA 1 0.0004
526 ANAL ABSCESS 2 0.0004
527 INFLAMMATION 19 0.0004
528 HERPES ZOSTER 21 0.0004
529 CARDIAC FAILURE 29 0.0004
530 GASTRIC ULCER HAEMORRHAGE 2 0.0004
531 NECROSIS 2 0.0004
532 ANAL HAEMORRHAGE 1 0.0004
533 BLOOD CALCIUM DECREASED 4 0.0004
534 DISORIENTATION 14 0.0004
535 HAEMATOCRIT DECREASED 7 0.0004
536 FACIAL PARALYSIS 3 0.0004
537 HERPES VIRUS INFECTION 2 0.0003
538 HYPOKALAEMIA 16 0.0003
539 ESCHERICHIA SEPSIS 1 0.0003
540 ADENOVIRUS INFECTION 1 0.0003
541 METABOLIC DISORDER 2 0.0003
542 ELECTROLYTE IMBALANCE 4 0.0003
543 BODY TEMPERATURE INCREASED 7 0.0003
544 LUNG INFILTRATION 3 0.0003
545 PLEURISY 2 0.0003
546 GASTROINTESTINAL INFECTION 3 0.0003
547 ATYPICAL PNEUMONIA 1 0.0003
548 BLOOD CULTURE POSITIVE 1 0.0003
549 HYPERCAPNIA 1 0.0003
550 INFUSION RELATED REACTION 22 0.0003
551 HEPATIC FAILURE 10 0.0003
552 PLATELET COUNT ABNORMAL 2 0.0003
553 LIVER FUNCTION TEST INCREASED 7 0.0003
554 UROSEPSIS 3 0.0003
555 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
556 HYPOTENSION 65 0.0003
557 CHOLANGITIS 2 0.0003
558 SQUAMOUS CELL CARCINOMA 3 0.0003
559 BRAIN OEDEMA 4 0.0003
560 TRANSAMINASES INCREASED 7 0.0003
561 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
562 AUTOIMMUNE DISORDER 3 0.0003
563 BEDRIDDEN 4 0.0003
564 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
565 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
566 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
567 RENAL IMPAIRMENT 25 0.0003
568 BRONCHIECTASIS 2 0.0003
569 HEPATIC CYST 1 0.0003
570 NEUTROPHIL COUNT INCREASED 3 0.0003
571 JOINT EFFUSION 2 0.0003
572 BLOOD CREATININE ABNORMAL 1 0.0003
573 DEPRESSIVE SYMPTOM 1 0.0003
574 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
575 FIBRIN D DIMER INCREASED 1 0.0003
576 HAEMORRHAGIC DIATHESIS 1 0.0003
577 ABDOMINAL PAIN LOWER 7 0.0003
578 FAECES DISCOLOURED 6 0.0003
579 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
580 BLOOD PHOSPHORUS DECREASED 1 0.0003
581 NEUROPATHY PERIPHERAL 26 0.0003
582 DRUG RESISTANCE 7 0.0003
583 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
584 RASH MACULO-PAPULAR 6 0.0003
585 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
586 HAEMORRHAGE INTRACRANIAL 4 0.0003
587 SKIN INFECTION 3 0.0003
588 HYPONATRAEMIA 15 0.0003
589 EYE INFECTION 3 0.0003
590 BLOOD SODIUM DECREASED 5 0.0003
591 HYPOCALCAEMIA 5 0.0003
592 HEPATOCELLULAR CARCINOMA 2 0.0003
593 TROPONIN INCREASED 2 0.0003
594 ADVERSE EVENT 24 0.0003
595 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
596 PERICARDIAL EFFUSION 6 0.0003
597 HAEMOLYSIS 2 0.0003
598 APNOEA 2 0.0003
599 CARDIOPULMONARY FAILURE 1 0.0003
600 CHILLS 30 0.0003
601 ACUTE KIDNEY INJURY 39 0.0003
602 BLOOD ALBUMIN DECREASED 2 0.0003
603 RENAL CYST 2 0.0003
604 CEREBRAL ATROPHY 1 0.0003
605 PRODUCT ADMINISTRATION ERROR 5 0.0002
606 ADRENAL INSUFFICIENCY 3 0.0002
607 CEREBRAL INFARCTION 6 0.0002
608 DEMYELINATION 1 0.0002
609 HYPERAESTHESIA 2 0.0002
610 EXTRAVASATION 1 0.0002
611 GENERALISED OEDEMA 3 0.0002
612 VENTRICULAR TACHYCARDIA 4 0.0002
613 PNEUMONIA ASPIRATION 6 0.0002
614 COAGULOPATHY 4 0.0002
615 COLITIS 9 0.0002
616 ACUTE MYOCARDIAL INFARCTION 7 0.0002
617 HAEMATEMESIS 6 0.0002
618 BUNDLE BRANCH BLOCK LEFT 1 0.0002
619 FEBRILE BONE MARROW APLASIA 1 0.0002
620 ABSCESS LIMB 1 0.0002
621 HAEMOGLOBIN DECREASED 24 0.0002
622 APHASIA 7 0.0002
623 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
624 URINE OUTPUT DECREASED 2 0.0002
625 DIVERTICULUM INTESTINAL 1 0.0002
626 BLOOD CALCIUM INCREASED 2 0.0002
627 ORAL CANDIDIASIS 3 0.0002
628 MELAENA 5 0.0002
629 ABDOMINAL ABSCESS 1 0.0002
630 DRUG ERUPTION 4 0.0002
631 UVEITIS 3 0.0002
632 LEUKOCYTOSIS 4 0.0002
633 HEPATIC ENZYME INCREASED 15 0.0002
634 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
635 DISEASE COMPLICATION 1 0.0002
636 MOVEMENT DISORDER 7 0.0002
637 INJECTION SITE REACTION 15 0.0002
638 ARTHRITIS INFECTIVE 1 0.0002
639 APPENDICITIS 2 0.0002
640 ILL-DEFINED DISORDER 13 0.0002
641 DEFORMITY 2 0.0002
642 BLOOD TEST ABNORMAL 3 0.0002
643 HEPATIC CIRRHOSIS 4 0.0002
644 LEUKAEMIA 2 0.0002
645 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
646 RED BLOOD CELL COUNT DECREASED 6 0.0002
647 PRODUCTIVE COUGH 10 0.0002
648 HYPOVOLAEMIC SHOCK 1 0.0002
649 CHOLESTASIS 4 0.0002
650 HAEMATURIA 7 0.0002
651 LABORATORY TEST ABNORMAL 6 0.0002
652 CARDIOMYOPATHY 3 0.0002
653 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
654 HYPERNATRAEMIA 1 0.0002
655 RESPIRATORY DISORDER 6 0.0002
656 DEEP VEIN THROMBOSIS 13 0.0002
657 HYPERKALAEMIA 7 0.0002
658 HYPOTHERMIA 2 0.0002
659 FEEDING DISORDER 4 0.0002
660 MOTOR DYSFUNCTION 2 0.0002
661 INJECTION SITE RASH 6 0.0002
662 CEREBRAL HAEMORRHAGE 7 0.0002
663 ENDOCARDITIS 1 0.0002
664 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
665 CACHEXIA 1 0.0002
666 CEREBRAL ISCHAEMIA 1 0.0002
667 EJECTION FRACTION DECREASED 3 0.0002
668 DEAFNESS 5 0.0002
669 CATATONIA 1 0.0002
670 FOOD CRAVING 1 0.0002
671 PANCREATITIS 10 0.0002
672 SUDDEN DEATH 2 0.0002
673 INFLUENZA 21 0.0002
674 COMPRESSION FRACTURE 1 0.0002
675 ANAL FISSURE 1 0.0002
676 DECREASED ACTIVITY 2 0.0002
677 ABDOMINAL PAIN 43 0.0002
678 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
679 STAPHYLOCOCCAL INFECTION 6 0.0002
680 HEPATOTOXICITY 4 0.0002
681 NEPHROPATHY TOXIC 2 0.0002
682 ACUTE PULMONARY OEDEMA 1 0.0002
683 FACE OEDEMA 3 0.0002
684 MITRAL VALVE INCOMPETENCE 2 0.0002
685 CHOLECYSTITIS ACUTE 1 0.0002
686 BACK PAIN 41 0.0002
687 MYOCARDIAL ISCHAEMIA 2 0.0002
688 CARDIAC VALVE DISEASE 1 0.0002
689 HYPERTONIA 1 0.0002
690 METASTASES TO LUNG 2 0.0002
691 EYELID OEDEMA 2 0.0002
692 VASCULITIS 2 0.0002
693 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
694 EOSINOPHILIA 3 0.0002
695 HYPERTRIGLYCERIDAEMIA 1 0.0002
696 CARDIO-RESPIRATORY ARREST 7 0.0002
697 BLOOD POTASSIUM DECREASED 5 0.0002
698 OEDEMA 9 0.0002
699 HYPERGLYCAEMIA 6 0.0002
700 LIVER INJURY 4 0.0002
701 TOOTH EXTRACTION 2 0.0002
702 PEMPHIGUS 2 0.0002
703 PRODUCT USE ISSUE 30 0.0002
704 FRACTURE 3 0.0002
705 CARDIAC ARREST 13 0.0002
706 HAEMOGLOBIN ABNORMAL 1 0.0002
707 INJECTION SITE INDURATION 2 0.0002
708 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
709 URINARY TRACT INFECTION 26 0.0002
710 MALIGNANT MELANOMA 2 0.0001
711 COLITIS ISCHAEMIC 1 0.0001
712 ARRHYTHMIA 7 0.0001
713 HYPERHIDROSIS 19 0.0001
714 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
715 DECREASED APPETITE 34 0.0001
716 ACUTE HEPATIC FAILURE 2 0.0001
717 PRODUCT PREPARATION ERROR 3 0.0001
718 PERIPHERAL COLDNESS 2 0.0001
719 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
720 HAEMATOCHEZIA 8 0.0001
721 DIVERTICULITIS 4 0.0001
722 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
723 MENTAL STATUS CHANGES 4 0.0001
724 AUTOIMMUNE HEPATITIS 1 0.0001
725 HYPOMAGNESAEMIA 2 0.0001
726 HOSPITALISATION 22 0.0001
727 RENAL FAILURE 19 0.0001
728 LUNG DISORDER 7 0.0001
729 DEFAECATION URGENCY 1 0.0001
730 CONFUSIONAL STATE 23 0.0001
731 MUSCULAR WEAKNESS 16 0.0001
732 BRONCHOSPASM 2 0.0001
733 OEDEMA PERIPHERAL 17 0.0001
734 DYSSTASIA 4 0.0001
735 UNDERDOSE 10 0.0001
736 PSYCHOTIC DISORDER 4 0.0001
737 CEREBRAL DISORDER 1 0.0001
738 TACHYCARDIA 12 0.0001
739 RENAL INJURY 4 0.0001
740 PULMONARY MASS 2 0.0001
741 GASTROINTESTINAL DISORDER 12 0.0001
742 INTESTINAL OBSTRUCTION 5 0.0001
743 HAEMODYNAMIC INSTABILITY 1 0.0001
744 EPILEPSY 4 0.0001
745 ACIDOSIS 1 0.0001
746 ATRIOVENTRICULAR BLOCK 1 0.0001
747 GASTROINTESTINAL INFLAMMATION 1 0.0001
748 PULMONARY EMBOLISM 12 0.0001
749 FURUNCLE 1 0.0001
750 PNEUMOTHORAX 2 0.0001
751 ULCER 2 0.0001
752 ABSCESS 2 0.0001
753 NEURALGIA 3 0.0001
754 BLOOD POTASSIUM INCREASED 2 0.0001
755 ABNORMAL FAECES 1 0.0001
756 HICCUPS 1 0.0001
757 ESCHERICHIA INFECTION 1 0.0001
758 ACUTE CORONARY SYNDROME 1 0.0001
759 HEMIPLEGIA 1 0.0001
760 BLOOD UREA INCREASED 2 0.0001
761 CARDIOVASCULAR DISORDER 3 0.0001
762 HEMIPARESIS 2 0.0001
763 SWELLING 11 0.0001
764 HEPATITIS 3 0.0001
765 ANURIA 1 0.0001
766 ORTHOSTATIC HYPOTENSION 2 0.0001
767 RASH 50 0.0001
768 COUGH 32 0.0001
769 GROIN PAIN 1 0.0001
770 GRIP STRENGTH DECREASED 1 0.0001
771 SEIZURE 13 0.0001
772 FACIAL PAIN 1 0.0001
773 THERAPY INTERRUPTED 8 0.0001
774 PELVIC PAIN 2 0.0001
775 BRAIN NEOPLASM 1 0.0001
776 FEELING COLD 3 0.0001
777 HEPATIC STEATOSIS 2 0.0001
778 RENAL DISORDER 5 0.0001
779 ERYTHEMA MULTIFORME 1 0.0001
780 FLANK PAIN 1 0.0001
781 DYSARTHRIA 4 0.0001
782 ARTERIOSCLEROSIS 1 0.0001
783 GASTRIC ULCER 2 0.0001
784 PULMONARY FIBROSIS 2 0.0001
785 LIVER FUNCTION TEST ABNORMAL 3 0.0001
786 HEPATOMEGALY 1 0.0001
787 URINARY INCONTINENCE 3 0.0001
788 HOSPICE CARE 1 0.0001
789 OESOPHAGEAL CARCINOMA 3 0.0001
790 ASTHENIA 38 0.0001
791 BLADDER DISORDER 1 0.0001
792 HYPOTONIA 1 0.0001
793 EMPHYSEMA 1 0.0001
794 EYELID PTOSIS 1 0.0001
795 ERYTHEMA 20 0.0001
796 INJECTION SITE WARMTH 2 0.0001
797 CARDIAC DISORDER 9 0.0001
798 MUSCULOSKELETAL PAIN 5 0.0001
799 SPEECH DISORDER 5 0.0001
800 BRONCHITIS 7 0.0001
801 CYSTITIS 3 0.0001
802 HYPOTHYROIDISM 3 0.0001
803 EATING DISORDER 2 0.0001
804 DRUG INTOLERANCE 9 0.0001
805 OVERDOSE 20 0.0001
806 DRUG INEFFECTIVE 121 0.0001
807 CHOLELITHIASIS 3 0.0001
808 PRODUCT STORAGE ERROR 8 0.0001
809 VISUAL ACUITY REDUCED 3 0.0001
810 STEVENS-JOHNSON SYNDROME 2 0.0001
811 INJECTION SITE PRURITUS 6 0.0001
812 PANCREATITIS ACUTE 2 0.0001
813 INJECTION SITE ERYTHEMA 11 0.0001
814 SINUSITIS 9 0.0001
815 VOMITING 41 0.0001
816 COGNITIVE DISORDER 4 0.0001
817 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
818 ATAXIA 1 0.0001
819 DISEASE RECURRENCE 4 0.0001
820 MOBILITY DECREASED 6 0.0001
821 CONSTIPATION 18 0.0001
822 HYPOGLYCAEMIA 4 0.0001
823 THERAPEUTIC RESPONSE DECREASED 5 0.0001
824 INJECTION SITE URTICARIA 2 0.0001
825 HEART RATE INCREASED 8 0.0001
826 DIARRHOEA 52 0.0001
827 ILEUS 1 0.0001
828 AGEUSIA 2 0.0001
829 MALAISE 35 0.0001
830 CELLULITIS 4 0.0001
831 CHEST DISCOMFORT 8 0.0001
832 DIPLOPIA 2 0.0001
833 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
834 ABNORMAL BEHAVIOUR 3 0.0001
835 ADVERSE REACTION 1 0.0001
836 CORONARY ARTERY OCCLUSION 1 0.0001
837 SKIN LESION 2 0.0001
838 INFLUENZA LIKE ILLNESS 6 0.0001
839 FATIGUE 56 0.0001
840 HAEMOPTYSIS 2 0.0001
841 APHONIA 1 0.0001
842 DEMENTIA 2 0.0001
843 DEVICE OCCLUSION 1 0.0001
844 HYPERTENSION 15 0.0001
845 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
846 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
847 HYPOKINESIA 1 0.0001
848 BONE PAIN 4 0.0001
849 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
850 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
851 HAEMORRHAGE 7 0.0001
852 HYPOAESTHESIA ORAL 1 0.0001
853 NEPHROLITHIASIS 3 0.0001
854 DYSPNOEA 37 0.0001
855 PAIN 40 0.0001
856 FEMUR FRACTURE 2 0.0001
857 SOMNOLENCE 13 0.0001
858 DELUSION 1 0.0001
859 BASAL CELL CARCINOMA 1 0.0001
860 DRUG-INDUCED LIVER INJURY 2 0.0001
861 PARAESTHESIA 10 0.0001
862 THROMBOSIS 5 0.0001
863 NIGHT SWEATS 2 0.0001
864 LACTIC ACIDOSIS 2 0.0001
865 EXPIRED PRODUCT ADMINISTERED 2 0.0001
866 TOXICITY TO VARIOUS AGENTS 10 0.0001
867 CONDITION AGGRAVATED 18 0.0001
868 MYALGIA 10 0.0001
869 CIRCULATORY COLLAPSE 1 0.0001
870 ABDOMINAL DISTENSION 6 0.0001
871 FALL 19 0.0001
872 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
873 GOUT 1 0.0001
874 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
875 NAUSEA 44 0.0001
876 GASTROENTERITIS VIRAL 1 0.0001
877 PRODUCT DOSE OMISSION ISSUE 16 0.0001
878 HEADACHE 34 0.0001
879 CONJUNCTIVITIS 1 0.0001
880 EPISTAXIS 4 0.0001
881 FOOT FRACTURE 1 0.0001
882 DYSPHAGIA 5 0.0001
883 FEELING JITTERY 1 0.0001
884 INJECTION SITE SWELLING 4 0.0001
885 LETHARGY 3 0.0001
886 ACUTE RESPIRATORY FAILURE 1 0.0001
887 EAR PAIN 1 0.0001
888 DYSPHONIA 3 0.0001
889 HAEMORRHOIDS 1 0.0001
890 WHEEZING 3 0.0001
891 CATARACT 3 0.0001
892 BLOOD PRESSURE ABNORMAL 1 0.0001
893 IRRITABILITY 3 0.0000
894 BONE MARROW FAILURE 1 0.0000
895 DISCOMFORT 3 0.0000
896 BLINDNESS 2 0.0000
897 ABDOMINAL PAIN UPPER 10 0.0000
898 POLLAKIURIA 2 0.0000
899 DERMATITIS 1 0.0000
900 HYPOAESTHESIA 7 0.0000
901 SWELLING FACE 3 0.0000
902 PULMONARY OEDEMA 2 0.0000
903 CHROMATURIA 1 0.0000
904 MEMORY IMPAIRMENT 6 0.0000
905 MUSCLE SPASMS 8 0.0000
906 TREMOR 7 0.0000
907 PRURITUS 16 0.0000
908 HEPATIC CANCER 1 0.0000
909 AGITATION 3 0.0000
910 PAIN IN EXTREMITY 12 0.0000
911 ENCEPHALOPATHY 1 0.0000
912 SYNCOPE 4 0.0000
913 AGGRESSION 2 0.0000
914 BLOOD PRESSURE INCREASED 6 0.0000
915 HYPOPHAGIA 1 0.0000
916 ERECTILE DYSFUNCTION 1 0.0000
917 DEPRESSED MOOD 2 0.0000
918 EAR INFECTION 1 0.0000
919 BLOOD GLUCOSE INCREASED 7 0.0000
920 RASH PRURITIC 2 0.0000
921 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
922 TREATMENT FAILURE 3 0.0000
923 EYE PAIN 2 0.0000
924 CEREBROVASCULAR ACCIDENT 6 0.0000
925 ANGINA PECTORIS 1 0.0000
926 MYOCARDIAL INFARCTION 6 0.0000
927 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
928 INSOMNIA 9 0.0000
929 ARTHRALGIA 14 0.0000
930 FEELING HOT 2 0.0000
931 NASOPHARYNGITIS 6 0.0000
932 EMOTIONAL DISORDER 1 0.0000
933 LOSS OF CONSCIOUSNESS 4 0.0000
934 CONTUSION 3 0.0000
935 HIP FRACTURE 1 0.0000
936 RHINORRHOEA 2 0.0000
937 EYE DISORDER 1 0.0000
938 DEHYDRATION 4 0.0000
939 GAIT INABILITY 1 0.0000
940 FLUSHING 3 0.0000
941 ILLNESS 3 0.0000
942 DEVICE USE ERROR 1 0.0000
943 SLEEP DISORDER 2 0.0000
944 DYSURIA 1 0.0000
945 DIZZINESS 13 0.0000
946 PERIPHERAL SWELLING 4 0.0000
947 ARTHRITIS 2 0.0000
948 WEIGHT DECREASED 7 0.0000
949 FEELING ABNORMAL 6 0.0000
950 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
951 DEVICE BREAKAGE 1 0.0000
952 DYSKINESIA 1 0.0000
953 COMPLETED SUICIDE 2 0.0000
954 BALANCE DISORDER 2 0.0000
955 WEIGHT INCREASED 5 0.0000
956 ADVERSE DRUG REACTION 2 0.0000
957 OROPHARYNGEAL PAIN 2 0.0000
958 CHEST PAIN 4 0.0000
959 HYPERSENSITIVITY 4 0.0000
960 BLOOD CHOLESTEROL INCREASED 1 0.0000
961 COMA 1 0.0000
962 BLOOD GLUCOSE DECREASED 1 0.0000
963 DYSPEPSIA 2 0.0000
964 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
965 DRUG INTERACTION 3 0.0000
966 ANAPHYLACTIC REACTION 1 0.0000
967 URTICARIA 3 0.0000
968 ABDOMINAL DISCOMFORT 3 0.0000
969 BLISTER 1 0.0000
970 ANXIETY 5 0.0000
971 VISUAL IMPAIRMENT 2 0.0000
972 AMNESIA 1 0.0000
973 BURNING SENSATION 1 0.0000
974 DYSGEUSIA 1 0.0000
975 HALLUCINATION 1 0.0000
976 ACNE 1 0.0000
977 CHRONIC KIDNEY DISEASE 1 0.0000
978 DIABETES MELLITUS 1 0.0000
979 INJECTION SITE PAIN 4 0.0000
980 BREAST CANCER 1 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
982 INCORRECT DOSE ADMINISTERED 2 0.0000
983 EMOTIONAL DISTRESS 1 0.0000
984 GAIT DISTURBANCE 1 0.0000
985 ALOPECIA 1 0.0000
986 DEPRESSION 1 0.0000